Lymphoma, Leukemia, Multiple Myeloma: Clinical Trials, CAR T \u0026 More | Dr. David Miklos, Stanford

(39:59)

Durability \u0026 safety of CD22-directed CAR T-cells for patients with LBCL progressing on CD19 CAR-T

(2:16)

CAR T Therapy: Clinical Trials and Updates | Dr. David Miklos, Stanford | The Patient Story

(12:16)

Allogeneic Transplants \u0026 Graft-Versus-Host Disease (GVHD) | Dr. David Miklos, Stanford

(13:34)

2019 MCHRI Symposium - David Miklos

(15:58)

Mantle Cell Lymphoma: Latest Treatments | Dr. David Miklos, Stanford | The Patient Story

(13:17)

David Miklos, MD, PhD, on the possible combination of ibrutinib and CAR T-cell therapies

(1:32)

Μενέλαος Τασιόπουλος: Το κλειδί-Τι κατάλαβαν οι Ρώσοι \u0026 ανταποκρίνονται στο άνοιγμα των Αμερικανών

(13:6)

The tragic moment Raphael Dwamena had a heart attack

(1:15)

Bene Gábor: Üzenet a Magyar Népnek! Sándorpalota 2024 02 21

(33:33)

ΔΕΝ ΕΧΩ ΟΞΥΓΟΝΟ | Η μεγαλειώδης συγκέντρωση για τα Τέμπη

(3:39)

Parkside Performance PPKSA 40 Li A1 Cordless chainsaw

(20:21)

Le temps des paysans - Désastres et révoltes

(54:12)

Κωνσταντίνος Λάβδας: Η Γαλλία βάζει πυρηνικά, η Γερμανία σπάει ταμπού, οι ΗΠΑ ξεσκονίζουν εγχειρίδια

(13:41)

Rozsa! (Random Reviews from the Overflow Room)

(9:29)

Μανώλης Λιδάκης – Συγκινεί ο Ανδρέας Μικρούτσικος για την γνωριμία τους: «Αδίκησε τον εαυτό του»

(8:41)

What To Do If You Don't Have A Product Owner

(6:7)

The significance of increased clonal hematopoiesis mutation allele frequency after CAR-T therapy

(2:56)

Optimizing CD19 CAR T-cell delivery for patients with R/R aggressive lymphoma

(2:52)

David Miklos, MD, PhD: Ibrutinib in Chronic Graft-Versus-Host Disease

(9:28)

Cellular Immunotherapy: Living Therapy | Stanford Cancer Institute

(2:18)

David Miklos, MD, on the impact stem cell and bone marrow transplant have on patients

(1:49)

David Miklos, MD, PhD, explains how ibrutinib is being studied for the treatment of GVHD

(1:51)

Clinical Impact of H-Y Alloimmunization by David Miklos, MD, PhD

(21:21)

Real-world data on axi-cel for patients with large B-cell lymphoma

(3:5)

David Miklos, MD, on developing an orphan drug for a small population of patients

(1:9)

NPA Report: David Miklos

(23:1econd)

David Miklos, MD, PhD, describes the optimal way to use ibrutinib in the treatment of GVHD

(1:44)

Ongoing CAR-T stewardship: monitoring the long-term safety of these therapies \u0026 reassuring patients

(1:49)